Scarica l'app Stockscreener
1.96
1.01%
-0.02
Heartsciences Inc Borsa (HSCS) Ultime notizie
HeartSciences Inc. Warrant (HSCSW) Slides 15% as Price Hovers at Key $0.05 LevelLow Volatility Picks - Newser
HeartSciences Inc. (HSCS) Q1 2026 Earnings: Wider-Than-Expected Loss Narrows on Strong Cost Control, Shares RallyBanking Earnings Report - Newser
HSCS Q1 2026 Earnings: EPS Surpasses Estimates as HeartSciences Advances Development PipelineEarnings Revision Report - Newser
HeartSciences signs North Shore Health for MyoVista platform - Investing.com UK
HeartSciences signs North Shore Health for MyoVista platform By Investing.com - Investing.com Nigeria
Rural Minnesota hospital adopts AI ECG platform endorsed by 127-hospital network - Stock Titan
HeartSciences Stockholders Approve Director Election and Equity Plan - TipRanks
What HeartSciences HSCS accounting reveals about the business Q1 2026 EPS Tops ViewsRestructuring - Newser
HeartSciences (HSCS) Reports Strong Q1 2026 — Revenue $N/A, EPS BeatsMarket Hype Signals - newser.com
TradingKey - TradingKey
HeartSciences (HSCS) Stock: Slides -3.53%, Support at $1.74 2026-05-14Gamma Alerts - Newser
HeartSciences (HSCSW) Stalls at $$0.06 — Breakout or Breakdown? 2026-05-14Collaborative Trading Signals - newser.com
What HeartSciences (HSCS) accounting reveals about the business | Q1 2026: EPS Tops ViewsCommunity Volume Signals - newser.com
What HeartSciences (HSCSW) disclosed about liquidity position | HSCSW Q3 Earnings: HeartSciences Warrant Shows No Revenue DataEarnings Risk - Newser
The technology investments behind HeartSciences (HSCSW) growth | HSCSW Q1 Earnings: HeartSciences Revenue Data UnavailableFinancial Health - Newser
HSCSW HeartSciences quarterly results show strategic progress as innovation pipeline drives growth, CEO upbeat on outlook.Cyclicality - newser.com
HeartSciences Inc. 2026 Annual Meeting 8-K Filing: Company Details, Stockholder Votes, and Corporate Governance Updates - Minichart
HeartSciences (NASDAQ: HSCS) 2026 meeting backs director, auditor, adjournment - Stock Titan
HeartSciences signs first SaaS revenues agreement following full launch of MyoVista Insights(TM) - marketscreener.com
HeartSciences Signs First SaaS Revenues Agreement following full launch of MyoVista Insights™ - The Manila Times
HeartSciences Signs First SaaS Revenues Agreement following full launch of MyoVista Insights - Weekly Voice
Heartsciences Signs First Saas Revenues Agreement Following Full Launch Of Myovista Insights - TradingView
Colorado hospital becomes first paying MyoVista Insights customer - Stock Titan
Heartsciences Signs Commercial Agreement with St. Vincent Health for MyoVista Insights SaaS Deployment - marketscreener.com
HeartSciences (HSCS) Detailed Report | Q1 2026: EPS Tops ViewsDirect Listing - Cổng thông tin điện tử tỉnh Lào Cai
HSCS (HeartSciences Inc.) reports narrower Q1 2026 loss than analyst estimates even as yearly revenue falls sharply, lifting its shares modestly.Debt Refinancing - UBND thành phố Hải Phòng
HSCS (HeartSciences) shares drop 3.2 percent despite Q1 2026 EPS beat as revenue plummets year over year.Dividend Suspension - Cổng thông tin điện tử tỉnh Tây Ninh
HeartSciences (HSCS) Stock Prediction: What’s Next After Recent Move (Breakdown Watch) 2026-04-20Social Flow Trades - Newser
HeartSciences (HSCS) Stock: Why Options Traders Watch It (Marginal Gain) 2026-04-15Insider Selling - Cổng thông tin điện tử Tỉnh Sơn La
HeartSciences Reminds Its Shareholders to Submit Their Vote at the Upcoming April 30, 2026, Annual Shareholders Meeting - 富途牛牛
HeartSciences shareholders have until April 29 to vote online - Stock Titan
Growth Report: Does HeartSciences Inc offer margin of safety2026 Snapshot & Safe Entry Trade Reports - baoquankhu1.vn
Can HeartSciences (HSCS) Stock Reach New Highs | Price at $2.29, Up 0.66%Short Setup - Newser
Is HeartSciences (HSCS) Stock Slowing Down | Price at $2.26, Down 1.74%Stock Analysis - Newser
HeartSciences Announces Passing of COO Mark Hilz; No Changes to Product Plans or Leadership Structure - Minichart
HeartSciences reports passing of COO Mark Hilz, will not seek immediate replacement - Investing.com Australia
HeartSciences COO and Longtime Board Member Passes Away - TipRanks
HeartSc's COO Mark Hilz dies; served on board since 2013 - TradingView
HeartSciences (HSCS) announces death of COO and director, affirms business plans - Stock Titan
Aug Highlights: Is HeartSciences Inc in a long term uptrend2026 Selloffs & Free Growth Oriented Trading Recommendations - baoquankhu1.vn
Exit Recap: Can HeartSciences Inc Equity Warrant outperform under higher oil prices2026 Institutional & Reliable Price Breakout Alerts - baoquankhu1.vn
Aug Retail: Can HeartSciences Inc expand its profit margins2026 Geopolitical Influence & Weekly Setup with High ROI Potential - baoquankhu1.vn
Big Picture: Will HeartSciences Inc Equity Warrant benefit from geopolitical trendsGlobal Markets & Verified Momentum Stock Watchlist - baoquankhu1.vn
HSCSW SEC FilingsHeartSciences Inc 10-K, 10-Q, 8-K Forms - Stock Titan
HeartSciences’ MyoVista Insights™ Receives Epic Toolbox Designation for ECG Management System Category - The Manila Times
HeartSciences lands Epic Toolbox spot for ECG workflow software - Stock Titan
0.32%
0.17%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):